Core Capabilities

Point-of-care, home-use, and laboratory diagnostics where analytical, clinical, and human factors evidence come together to enable commercialization across professional, prescription, and over-the-counter settings

Drug-eluting stents, biologic-coated implants, and drug delivery systems where drugs, devices, and biologics converge, requiring cross-disciplinary regulatory strategies and partnerships for commercialization.

Cell manufacturing platforms, bioprocessing technologies, and enabling tools where materials, design, scalability, quality systems, and regulatory requirements converge to enable translation from research to commercialization.